Fig. 6: Baseline characteristics of LAPC compared to metastatic cases enrolled on COMPASS.
From: Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial
Boxplots in Panel A, B, D-F depict 1st quartile, median and 3rd quartile +/− 1.5 interquartile range. P-values derived from two-sided Wilcoxon rank sum test. A BMI in locally advanced (stage III, n = 37) compared to stage IV cases. B CA19.9 in locally advanced (stage III, n = 37) compared to stage IV cases. C Frequency of GRIm-S low (0) or high (2) in locally advanced (stage III, n = 37) compared to stage IV cases. Molecular features of LAPC (n = 37) compared to met PDAC (n = 231) D SNV count in locally advanced vs stage IV cases, E indel count and F structural variant count and G frequency of Moffitt basal-like vs classic subtype.
